AbCellera Biologics (ABCL) Property, Plant & Equipment (Net) (2020 - 2026)

AbCellera Biologics (ABCL) Property, Plant & Equipment (Net) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 642,333.36
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 5.32 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 31.48 Mn
10 AbCellera Biologics 1.61 Bn 1.61 Bn - 422.81 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 422.81 Mn
Mar 31, 2026 422.81 Mn
Dec 31, 2025 428.00 Mn
Dec 31, 2025 428.00 Mn
Sep 30, 2025 427.36 Mn
Sep 30, 2025 427.36 Mn
Jun 30, 2025 424.02 Mn
Jun 30, 2025 424.02 Mn
Mar 31, 2025 347.10 Mn
Mar 31, 2025 347.10 Mn
Dec 31, 2024 340.43 Mn
Dec 31, 2024 340.43 Mn
Sep 30, 2024 331.26 Mn
Sep 30, 2024 331.26 Mn
Jun 30, 2024 318.88 Mn
Jun 30, 2024 318.88 Mn
Mar 31, 2024 306.08 Mn
Mar 31, 2024 306.08 Mn
Dec 31, 2023 287.70 Mn
Dec 31, 2023 287.70 Mn